Search research articles
Contact Us
Filters
Showing results (31-40 of 157) with videos related to
Page
of 16
Sort By:
International Journal of Pharmaceutics
|
May 27, 2014
Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex
Ruggero Angelico, Andrea Ceglie, Pasquale Sacco, et al.
Journal of Medical Economics
|
May 20, 2009
Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virus
Paola De Compadri, Daniela Koleva, Alessandra Mangia, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms
Valerio Pazienza, Sophie Clément, Paolo Pugnale, et al.
World Journal of Gastroenterology
|
July 30, 2014
Cytokinome profile evaluation in patients with hepatitis C virus infection
Francesca Capone, Eliana Guerriero, Giovanni Colonna, et al.
Hepatology (Baltimore, Md.)
|
April 29, 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans
Anastasia Asimakopoulos, Alessandra Mangia, Gregory J Dore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 23, 2008
Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins
Valerio Pazienza, Sophie Clément, Paolo Pugnale, et al.
BMC Gastroenterology
|
August 5, 2020
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
Alessandra Mangia, Davide Bellini, Umberto Cillo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 21, 2016
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin
Alessandra Mangia, Andrea Arleo, Massimiliano Copetti, et al.
Hepato-Gastroenterology
|
July 10, 2015
Treatment Outcomes and Predictors of Response in Treatment-Naive HCV Patients Treated with Peginterferon Alfa/Ribavirin in Real-World Italian Clinics: Sub-Analysis from the PROPHESYS Cohort
Antonio Ascione, Savino Bruno, Carmine Coppola, et al.
Pathologica
|
July 23, 2021
Pathology of non-alcoholic fatty liver disease
Ivana Cataldo, Samantha Sarcognato, Diana Sacchi, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 157) with videos related to
Sort By:
Page
of 16
International Journal of Pharmaceutics
|
May 27, 2014
Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex
Ruggero Angelico, Andrea Ceglie, Pasquale Sacco, et al.
Journal of Medical Economics
|
May 20, 2009
Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virus
Paola De Compadri, Daniela Koleva, Alessandra Mangia, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms
Valerio Pazienza, Sophie Clément, Paolo Pugnale, et al.
World Journal of Gastroenterology
|
July 30, 2014
Cytokinome profile evaluation in patients with hepatitis C virus infection
Francesca Capone, Eliana Guerriero, Giovanni Colonna, et al.
Hepatology (Baltimore, Md.)
|
April 29, 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans
Anastasia Asimakopoulos, Alessandra Mangia, Gregory J Dore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 23, 2008
Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins
Valerio Pazienza, Sophie Clément, Paolo Pugnale, et al.
BMC Gastroenterology
|
August 5, 2020
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
Alessandra Mangia, Davide Bellini, Umberto Cillo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 21, 2016
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin
Alessandra Mangia, Andrea Arleo, Massimiliano Copetti, et al.
Hepato-Gastroenterology
|
July 10, 2015
Treatment Outcomes and Predictors of Response in Treatment-Naive HCV Patients Treated with Peginterferon Alfa/Ribavirin in Real-World Italian Clinics: Sub-Analysis from the PROPHESYS Cohort
Antonio Ascione, Savino Bruno, Carmine Coppola, et al.
Pathologica
|
July 23, 2021
Pathology of non-alcoholic fatty liver disease
Ivana Cataldo, Samantha Sarcognato, Diana Sacchi, et al.
Page
of 16